The present disclosure pertains to medical devices, and methods for manufacturing and using medical devices. More particularly, the disclosure is directed to devices and methods for removing occlusive material from a body lumen. Further, the disclosure is directed to an atherectomy device for forming a passageway through an occlusion of a body lumen, such as a blood vessel.
A wide variety of medical devices have been developed for medical use, for example, for use in accessing body cavities and interacting with fluids and structures in body cavities. Some of these devices may include guidewires, catheters, pumps, motors, controllers, filters, grinders, needles, valves, and delivery devices and/or systems used for delivering such devices. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. As an example, an atherectomy system includes an atherectomy burr having one or more blood flow enhancement features that permit an increased level of blood flow past the burr relative to a blood flow that would result absent the one or more flow enhancement features. The atherectomy burr includes a burr body and an outer surface as well as a drive mechanism that is adapted to rotatably actuate the atherectomy burr.
Alternatively or additionally, the drive mechanism may include a drive cable that is adapted to be coupled with the atherectomy burr and a prime mover that is adapted to rotate the drive cable.
Alternatively or additionally, an outer surface of the atherectomy burr may include an abrasive material.
Alternatively or additionally, substantially all of the plaque that is removed during operation of the atherectomy system may be removed by the abrasive material.
Alternatively or additionally, the one or more blood flow enhancement features may include blood flow grooves formed within the outer surface of the atherectomy burr.
Alternatively or additionally, the blood flow grooves may have a rounded over edge having a radius of curvatures sufficient to not provide a cutting edge.
Alternatively or additionally, the radius of curvature may be at least 0.0001 inches.
Alternatively or additionally, the one or more blood flow enhancement features may include a single asymmetric cut within the burr body.
Alternatively or additionally, the blood flow grooves may include a plurality of symmetrically arranged blood flow grooves extending axially along a length of the burr body.
Alternatively or additionally, the blood flow grooves may include one or more blood flow grooves extending spirally along a length of the burr body.
Alternatively or additionally, the one or more blood flow enhancement features may include one or more blood flow channels that pass through an interior of the burr body.
Alternatively or additionally, at least one of the one or more blood flow channels may extend axially through the interior of the burr body.
Alternatively or additionally, at least one of the one or more blood flow channels may extend radially into the interior of the burr body.
As another example, an atherectomy burr may be adapted for use in a rotational atherectomy system. The atherectomy burr includes an atherectomy burr body extending from a distal region to a proximal region thereof and adapted to be secured relative to a drive cable of a rotational atherectomy system. The atherectomy burr body defines an outer surface and includes one or more blood flow enhancement features that are adapted to increase blood flow past the burr.
Alternatively or additionally, the one or more blood flow enhancement features may include blood flow grooves formed within the outer surface of the atherectomy burr.
Alternatively or additionally, the one or more blood flow enhancement features may include a single asymmetric cut within the burr body.
Alternatively or additionally, the one or more blood flow enhancement features may include a plurality of symmetrically arranged blood flow grooves extending axially along a length of the burr body.
Alternatively or additionally, the one or more blood flow enhancement features may include one or more blood flow grooves extending spirally along a length of the burr body.
Alternatively or additionally, the one or more blood flow enhancement features may include one or more blood flow channels that pass through an interior of the burr body.
Alternatively or additionally, the one or more blood flow enhancement features may include two or more blood flow channels that are asymmetrically arranged about the outer surface of the atherectomy burr.
Alternatively or additionally, the one or more flow enhancement features may be adapted to provide preferential cutting of inelastic material relative to elastic material.
Alternatively or additionally, the one or more blood flow enhancement features may include a flow channel formed within the outer surface of the atherectomy burr, where the flow channel includes a chamfered leading edge.
Alternatively or additionally, the flow channel may include a semi-spiral channel.
Alternatively or additionally, the flow channel may include a straight flow channel arranged at an angle with respect to a longitudinal axis of the atherectomy burr.
As another example, an atherectomy burr may be adapted for use in a rotational atherectomy system. The atherectomy burr includes an atherectomy burr body extending from a distal region to a proximal region thereof and adapted to be secured relative to a drive cable of a rotational atherectomy system. The atherectomy burr body defines an outer surface, with a first blood flow enhancing groove formed in the outer surface and extending at least a portion of a length of the burr body and a second blood flow enhancing groove formed in the outer surface and extending at least a portion of the length of the burr body, the second blood flow enhancing groove spaced about 180 degrees circumferentially from the first blood flow enhancing groove.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Cardiovascular disease and peripheral arterial disease may arise from accumulation of atheromatous material on the inner walls of vascular lumens, resulting in a condition known as atherosclerosis. Atheromatous and other vascular deposits may restrict blood flow and can cause ischemia in a heart of a patient, vasculature of a patient's legs, a patient's carotid artery, etc. Such ischemia may lead to pain, swelling, wounds that will not heal, amputation, stroke, myocardial infarction, and/or other conditions.
Atheromatous deposits may have widely varying properties, with some deposits being relatively soft or fatty, fibrous, or calcified. All are inelastic. The deposits may be referred to as plaque. Atherosclerosis occurs naturally as a result of aging, but may also be aggravated by factors such as diet, hypertension, heredity, vascular injury, and the like. Atherosclerosis may be treated in a variety of ways, including drugs, bypass surgery, and/or a variety of catheter-based approaches that may rely on intravascular widening or removal of the atheromatous or other material occluding the blood vessel. Atherectomy is a catheter-based intervention that may be used to treat atherosclerosis.
Atherectomy is an interventional medical procedure performed to restore a flow of blood through a portion of a patient's vasculature that has been blocked by plaque or other material (e.g., blocked by an occlusion). In an atherectomy procedure, a device on an end of a drive shaft is used to engage and/or remove (e.g., abrade, grind, cut, shave, etc.) plaque or other material from a patient's vessel (e.g., artery or vein). In some cases, the device on an end of the drive shaft may be abrasive and/or may otherwise be configured to remove plaque from a vessel wall or other obstruction in a vessel when the device is rotating and engages the plaque or other obstruction.
The atherectomy system 10 may include a drive assembly 12 and a control unit 14 (e.g., a controller). The drive assembly 12 may include, among other elements, an advancer assembly 16 and a rotation assembly 17. Although the control unit 14 is depicted as being separate from the drive assembly 12 in
The rotation assembly 17 may include a drive shaft 18 (e.g., an elongate member that may be or may include a flexible drive shaft or other suitable drive shaft), an atherectomy burr 20, and an elongate member 22 having a first end (e.g., a proximal end), a second end (e.g., a distal end), and a lumen extending from the first end to the second end for receiving the drive shaft 18. In some cases, the elongate member 22 may be an elongated tubular member. The atherectomy burr 20 may have a rough surface, such that it is configured to grind, abrade, etc. plaque from a vessel wall or other obstruction in a vessel when it is rotated.
The advancer assembly 16 may include a knob 23, a housing 26, a drive mechanism (internal to the advancer assembly and thus not visible), and/or one or more other suitable components. The housing 26 may at least partially house the drive mechanism and the knob 23 may be at least partially accessible from an exterior of the housing 26. The drive mechanism may be or may include a motor (e.g., an electric motor, pneumatic motor, or other suitable motor) at least partially housed within the housing 26 and in communication with the knob 23, the drive shaft 18, and the control unit 14. The knob 23 may be configured to advance along a longitudinal path to longitudinally advance the drive mechanism and the rotation assembly 17.
The drive mechanism may be coupled to the drive shaft 18 in a suitable manner including, but not limited to, a weld connection, a clamping connection, an adhesive connection, a threaded connection, and/or other suitable connection configured to withstand rotational speeds and forces. As the drive shaft 18 may rotate over a wide range of speeds (e.g., at speeds of between zero (0) RPM and 250,000 RPM or higher), the coupling between the drive mechanism and the drive shaft 18 may be configured to withstand such rotational speeds and associated forces.
The drive shaft 18 may be formed from one or more of a variety of materials. For example, the drive shaft 18 may be formed from one or more of a variety of materials, including steel, stainless steel, other metal, polymer, and/or other suitable materials.
The drive shaft 18 may have a suitable diameter and/or length for traversing vasculature of a patient. The diameter and/or the length of the drive shaft 18 may depend on the dimension of the lumen of the elongate member 22, the dimensions of vessels of a patient to be traversed, and/or one or more other suitable factors. In some cases, the drive shaft 18 may have a diameter in a range from about 0.030 centimeters (cm) or smaller to about 0.150 cm or larger and a working length in a range from about ten (10) cm or shorter to about three hundred (300) cm or longer. In one example, the drive shaft 18 may have a diameter of about 0.05715 cm and a length of about fifty (50) cm. Alternatively, the drive shaft 18 may have a different suitable diameter and/or different suitable length.
The atherectomy burr 20 may have an outer perimeter which is equal to or larger than a distal diameter of the drive shaft 18 and/or the elongate member 22. Alternatively or in addition, the atherectomy burr 20 may have an outer perimeter which is smaller than a diameter of the drive shaft 18 and/or the elongate member 22. The atherectomy burr 20 may have a symmetric design so that it penetrates equally well in both rotational directions, but this is not required and the atherectomy burr 20 may be configured to penetrate in only one rotational direction.
The atherectomy burr 20 may be coupled to the drive shaft 18. Where the drive shaft 18 has a first end portion (e.g., a proximal end portion) and a second end portion (e.g., a distal end portion), the atherectomy burr 20 may be coupled to the drive shaft 18 at or near the second end portion. In some cases, the atherectomy burr 20 may be located at or adjacent a terminal end of the second end portion of the drive shaft 18.
The atherectomy burr 20 may be coupled to the drive shaft 18 in any manner. For example, the atherectomy burr 20 may be coupled to the drive shaft 18 with an adhesive connection, a threaded connection, a weld connection, a clamping connection, and/or other suitable connection configured to withstand rotational speeds and forces. Similar to as discussed above with respect to the connection between the drive shaft 18 and the drive mechanism, as the drive shaft 18 and/or the atherectomy burr 20 may rotate at speeds between zero (0) RPM and 250,000 RPM or higher, the coupling between the drive shaft 18 and the atherectomy burr 20 may be configured to withstand such rotational speeds and associated forces.
The drive assembly 12 and the control unit 14 may be in communication and may be located in or may have a same housing and/or located in or have separate housings (e.g., the advancer assembly housing 26 and a control unit housing 28 or other housings). Whether in the same housing or in separate housings, the drive assembly 12 and the control unit 14 may be in communication through a wired connection (e.g., via one or more wires in an electrical connector 24 or other suitable electrical connector) and/or a wireless connection. Wireless connections may be made via one or more communication protocols including, but not limited to, cellular communication, ZigBee, Bluetooth, Wi-Fi, Infrared Data Association (IrDA), dedicated short range communication (DSRC), EnOcean, and/or any other suitable common or proprietary wireless protocol, as desired.
Although not necessarily shown in
The control unit 14, which may be separate from the drive assembly 12 (e.g., as shown in
In some cases, the control unit 14 may include one or more drive mechanism load output control mechanisms for controlling an operation of the atherectomy system 10. In one example of a drive mechanism load output control mechanism that may be included in the control unit 14, the control unit 14 may include a mechanism configured to set and/or adjust an advancing load output (e.g., a rotational speed) and/or a retracting load output from the drive mechanism. Additionally or alternatively, the control unit 14 may include other control and/or safety mechanism for controlling the operation of the atherectomy system 10 and mitigating risks to patients.
In use, there may be times in which the atherectomy burr 20 may partially or even completely occlude blood flow through a vessel, particularly when the atherectomy burr 20 is abrading into and/or through a calcified occlusion. The atherectomy burr 20 may have a diameter that is in the range of 1.25 millimeters (mm) to 5 mm and a length that is in the range of 4 mm to 8 mm. The atherectomy burr 20 may be considered as being adapted to remove calcified material via abrasion, rather than by cutting. The atherectomy burr 20 may include an abrasive material secured to an outer surface of the atherectomy burr 20. In some cases, the abrasive material may be diamond crystals or other diamond-based material.
In some cases, the atherectomy burr 20 may be adapted to permit blood flow through or past the atherectomy burr 20 in situations in which blood flow would be occluded, absent adaptations made to the atherectomy burr.
The first blood flow channel 52 and the second blood flow channel 54 may each have a cylindrical shape and may exit through the proximal region 46 of the burr body 42. At least one of the first blood flow channel 52 and the second blood flow channel 54, and any additional blood flow channels, if included, may have an ovoid cross-sectional shape. In some instances, the first blood flow channel 52 and the second blood flow channel 54, and any additional blood flow channels, if included, may have a circular cross-sectional shape, a rectilinear cross-sectional shape, a triangular cross-sectional shape, or any other desired cross-sectional shape. The first blood flow channel 52 and/or the second blood flow channel 54 may have a constant internal diameter. In some cases, the first blood flow channel 52 and/or the second blood flow channel 54 may have an internal diameter that increases moving proximally. In some cases, the first blood flow channel 52 and/or the second blood flow channel 54 may have an internal diameter that decreases moving proximally.
In some cases, the first blood flow channel 52 and/or the second blood flow channel 54 may have a circular cross-sectional shape having a diameter in the range of 0.0003 inches to 0.020 inches. In some cases, the first blood flow channel 52 and/or the second blood flow channel 54 may have a circular cross-sectional shape having a diameter that is at least partially dependent on the diameter of the atherectomy burr 40. A larger diameter burr can accommodate a relatively larger diameter blood flow channel, for example, while a smaller diameter burr may be more limited with respect to the size of blood flow channel that can be accommodated. Merely as an illustrative but non-limiting example, an atherectomy burr having a diameter of 1.5 millimeters may have blood flow channels having a diameter of 0.008 inches. An atherectomy burr having a diameter of 2.5 millimeters may have blood flow channels that are proportionally larger. An atherectomy burr having a diameter of 6 millimeters will also have blood flow channels that are proportionally larger.
It will be appreciated that blood cells have an average diameter of about 0.0003 inches, which may be considered as a practical lower limit to the size of the blood flow channels 52 and 54. In some cases, making the blood flow channels 52 and 54 as large as possible can provide increased fluid flow through the atherectomy burr 40, with relatively decreased frictional losses. As the diameter of the blood flow channels 52 and 54 decreases, it will be appreciated that frictional losses caused by boundary layers and other causes can substantially decrease fluid flow through the blood flow channels 52 and 54.
In some cases, the openings to the first blood flow channel 52 and the second blood flow channel 54 may have rounded over edges, such that the edges do not damage blood cells flowing towards and into the first blood flow channel 52 and the second blood flow channel 54. In some cases, the openings to the first blood flow channel 52 and the second blood flow channel 54 may have a radius of curvature that is up to 1 millimeters for smaller diameter atherectomy burrs and a radius of curvature that is up to 10 millimeters for larger diameter burrs. For example, the openings to the first blood flow channel 52 and the second blood flow channel 54 may have a radius of curvature in the range of 0.0001 inches to 0.020 inches.
While the asymmetric cut 72 is shown in
In some instances, the single asymmetric cut 72 has a semi-circular profile. In some cases, the single asymmetric cut 72 may have a flat or linear profile, as would result if one were to simply cut or grind away a portion of the curved burr body 62. The single asymmetric cut 72 may have dimensions of up to 25 percent of the burr diameter. While a single asymmetric cut 72 is illustrated, in some cases the atherectomy burr 60 may include two or more asymmetric cuts 72, spaced unequally around the burr body 62. Depending on how much of an orbital path is desired, the relative spacing between the two or more asymmetric cuts 72 can be varied. If there are two asymmetric cuts 72, for example, and a relatively small orbital path is desired, perhaps the two asymmetric cuts 72 may be spaced 150 to 170 degrees apart (as opposed to 180 degrees, which would be symmetric). If a relatively larger orbital path is desired, the two asymmetric cuts 72 could be spaced 120 degrees part, for example. It will be appreciated that having a larger cut, or having multiple cuts, will improve blood flow past the atherectomy burr 60 but may reduce the available amount of abrasive material. In determining how far apart the asymmetric cuts are spaced, it should be noted that the burr body 62 has a largely cylindrical profile nearer its proximal region 66 and a tapered profile nearer its distal region 64. Spacing may be considered as being defined within the largely cylindrical profile portion of the burr body 62.
In some cases, the edges of the asymmetric cut 72 may be rounded over, such that the edges do not damage blood cells flowing towards and into the asymmetric cut 72. In some cases, the edges of the asymmetric cut 72 may have a radius of curvature that is up to 1 millimeters for smaller diameter atherectomy burrs and a radius of curvature that is up to 10 millimeters for larger diameter burrs. For example, the edges of the asymmetric cut 72 may have a radius of curvature in the range of 0.0001 inches to 0.020 inches.
As shown, the first blood flow groove 92 and the second blood flow groove 94 are symmetrically arranged, being spaced 180 degrees apart. As a result, the first blood flow groove 92 and the second blood flow groove 94 will not materially alter the rotational patterns of the atherectomy burr 80. While two blood flow grooves 92, 94 are shown, it will be appreciated that there may be additional blood flow grooves. For example, the atherectomy burr 80 could include a total of three blood flow grooves, each spaced 120 degrees apart. In determining how far apart the blood flow grooves are spaced, it should be noted that the burr body 82 has a largely cylindrical profile nearer its proximal region 86 and a tapered profile nearer its distal region 84. Spacing may be considered as being defined within the largely cylindrical profile portion of the burr body 82. As illustrated, the first blood flow groove 92 and the second blood flow groove 94 each have a semi-circular profile. Each of the first blood flow groove 92 and the second blood flow groove 94 may have dimensions of up to 25 percent of the burr diameter.
In some cases, the edges of the first blood flow groove 92 and the second blood flow groove 94 may be rounded over, such that the edges do not damage blood cells flowing towards and into the first blood flow groove 92 and the second blood flow groove 94. In some cases, the edges of the first blood flow groove 92 and the second blood flow groove 94 may each have a radius of curvature that is up to 1 millimeters for smaller diameter atherectomy burrs and a radius of curvature that is up to 10 millimeters for larger diameter burrs. For example, the edges of the first blood flow groove 92 and the second blood flow groove 94 may have a radius of curvature in the range of 0.0001 inches to 0.020 inches.
In some cases, there may be additional blood flow grooves formed in the outer surface 104 of the burr body 102. For example, a total of five blood flow grooves could be spaced 72 degrees apart. A total of six blood flow grooves could be spaced 60 degrees apart. These are just examples. As shown, each of the blood flow grooves 108, 110, 112, 114 have a semi-circular profile. In some cases, it is contemplated that one or more of the blood flow grooves 108, 110, 112, 114 could have a V-shaped profile, for example, or a rectilinear profile.
Regardless of the overall shape of the blood flow grooves 108, 110, 112, 114, the edges between each of the blood flow grooves 108, 110, 112, 114 and the outer surface 104 are sufficiently rounded over to prevent the blood flow grooves 108, 110, 112, 114 from serving as cutting edges.
In some cases, the atherectomy burr 120 may include from two (2) to fifteen (14) fluted cuts. The atherectomy burr 120 may include from four (4) to ten (10) fluted cuts. The atherectomy burr 120 may include from six (6) to eight (8) fluted cuts. In some cases, the atherectomy burr 120 may include a total of six (6) or eight (8) fluted cuts. Each of the fluted cuts 130, 132, 134, 136 and 138 may have a length that ranges from ten (10) percent to one hundred (100) percent of a length of the atherectomy burr 120. Each of the fluted cuts 130, 132, 134, 136 and 138 may have a depth that ranges from near zero (0) to twenty five (25) percent of a diameter of the atherectomy burr 120. In the case of a six (6) millimeter diameter atherectomy burr, the depth may be as great as forty (40) percent of the diameter. Each of the fluted cuts 130, 132, 134, 136 and 138 may have a width that is up to fifty (50) percent of a diameter of the atherectomy burr 120, with a caveat that a combined width (adding the width of each of the fluted cuts) does not exceed ninety (90) or ninety five (95) percent of the diameter of the atherectomy burr 120.
The semi-spiral channel 210 may have a leading edge 211 that is substantially rounded or chamfered over a distance that ranges from 0.02 to 10 times a width of the blood flow channel, or a distance that ranges from 0.05 to 10 times the width of the blood flow channel provided by the semi-spiral channel 210. As a result, not only does the leading edge 211 not provide a cutting feature, but the leading edge 211 also provides for a gradual return of rebounded tissue residing in the semi-spiral channel 210 to a surface 212 that is equal to the burr maximum at each position in the longitudinal direction. Furthermore, the tissue is not engaged by diamond crystals 232 until it has stabilized in an orbit equal to the burr's maximum radius of gyration. As a result, healthy compliant tissue will not be engaged by the diamond crystals 232 beyond its elastic limit, thereby preserving differential cutting. Differential cutting refers to a process whereby diseased tissue having inelastic properties is differentially removed while healthy tissue, which is elastic, is spared.
Several burr designs were tested to see how the particular designs affected fluid flow past the burr. The tested designs are designated in the data below as Fluted (corresponding to
To perform the testing, burr blanks were loaded onto a production equivalent 0.009 section of ROTAWIRE DRIVE and this subassembly was loaded into a clear HDPE tube with a 1.75 mm ID in a near straight configuration. The tube had a slight memory from being on spool and was flooded with red food coloring dyed DI water. Tubing was placed into a 6F compatible Hemostasis valve with Y-luer adapter port such that the proximal end of the tubing was just distal to the point in the hemostasis valve where the ‘y’ connects. The entry point on the hemostasis valve was closed and the ‘y’ port was connected to a 1 L bag of DI water and food coloring that was pressurized to 200±25 mmHg via pressure cuff, which was monitored and repressured at the start and during each test. The distal end of the tube was place over a collection beaker that had been wet weighed with the DI/food coloring mix. The pressurized bag was open as a timer was started. The burrs were not separately driven into rotation during testing.
Fluid was collected in a beaker for roughly 30 seconds (within a margin of error for a human to close the IV line connecting the bag to the hemostasis valve. The fluid was weighed using a scale calibrated to ±0.5 g by weighing the beaker plus fluid and subtracting the weight of the empty beaker, where the empty beaker weighed 14.5 grams (g). Because water has a density of 1 g/ml, the net mass flow amounts listed below can also be considered as volumes, measured in milliliters (ml). The experimental data is shown below in Table One. The net mass data is graphically represented in
Several observations were made during testing. There was considerable variation between runs for the Fluted burr. For the runs with a higher flow amount (runs 2, 3 and 4), the flow of fluid through the tube caused the Fluted burr to begin rotating. The Fluted burr rotated at an estimated rotation speed of 5 to 10 revolutions per second. As the Fluted burr rotated, the design of the Fluted burr caused a pumping effect, further increasing fluid flow past the burr. For the runs with a lower flow amount (runs 1 and 5), the Fluted burr did not spin, as apparently there was sufficient friction between the Fluted burr and the side of the tubing (due to a small curve in the tubing) that prevented rotation.
With respect to the Scallop burr, regardless of how the Scallop burr was originally oriented within the tubing, as soon as flow began, the burr seemed to rotate to be on the inside of the slight curve in the tubing. This may have impacted the flow results for the Scallop burr.
For the Through Hole burr, an air pocket seems to have formed when pre-flooding the tube prior to collecting fluid. One possibility is that the fluid goes around the outside of the burr first, which doesn't allow any air trapped within the through holes to escape.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit under 35 USC 119 to U.S. Provisional Ser. No. 63/108,045, filed Oct. 30, 2020, which application is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2088654 | Hull | Aug 1937 | A |
3913196 | Maday | Oct 1975 | A |
3937222 | Banko | Feb 1976 | A |
4395167 | Maternus | Jul 1983 | A |
4507028 | Matsushita | Mar 1985 | A |
4679557 | Opie et al. | Jul 1987 | A |
4990134 | Auth | Feb 1991 | A |
5116350 | Stevens | May 1992 | A |
5287858 | Hammerslag et al. | Feb 1994 | A |
5308354 | Zacca et al. | May 1994 | A |
5314407 | Auth et al. | May 1994 | A |
5417703 | Brown et al. | May 1995 | A |
5478344 | Stone et al. | Dec 1995 | A |
5501694 | Ressemann et al. | Mar 1996 | A |
5540707 | Ressemann et al. | Jul 1996 | A |
5563481 | Krause | Oct 1996 | A |
5572609 | Li | Nov 1996 | A |
5626444 | Campian | May 1997 | A |
5632755 | Nordgren | May 1997 | A |
5674235 | Parisi | Oct 1997 | A |
5681336 | Clement et al. | Oct 1997 | A |
5709661 | Van Egmond et al. | Jan 1998 | A |
5766192 | Zacca | Jun 1998 | A |
5779722 | Shturman et al. | Jul 1998 | A |
5823990 | Henley | Oct 1998 | A |
5827323 | Klieman et al. | Oct 1998 | A |
5836868 | Ressemann et al. | Nov 1998 | A |
5899915 | Saadat | May 1999 | A |
5913867 | Dion | Jun 1999 | A |
6015420 | Wulfman et al. | Jan 2000 | A |
6017354 | Culp et al. | Jan 2000 | A |
6086608 | Ek et al. | Jul 2000 | A |
6102926 | Tartaglia et al. | Aug 2000 | A |
6106301 | Merril | Aug 2000 | A |
6113615 | Wulfman | Sep 2000 | A |
6120515 | Rogers et al. | Sep 2000 | A |
6126667 | Barry et al. | Oct 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6149663 | Strandberg et al. | Nov 2000 | A |
6171312 | Beaty | Jan 2001 | B1 |
6200329 | Fung et al. | Mar 2001 | B1 |
6212300 | Rengakuji | Apr 2001 | B1 |
6234725 | Campian | May 2001 | B1 |
6270509 | Barry | Aug 2001 | B1 |
6312438 | Adams | Nov 2001 | B1 |
6494888 | Laufer et al. | Dec 2002 | B1 |
6500186 | Lafontaine et al. | Dec 2002 | B2 |
6503227 | Guo et al. | Jan 2003 | B1 |
6503261 | Bruneau et al. | Jan 2003 | B1 |
6506196 | Laufer | Jan 2003 | B1 |
6554845 | Fleenor et al. | Apr 2003 | B1 |
6569085 | Kortenbach et al. | May 2003 | B2 |
6572630 | McGuckin, Jr. | Jun 2003 | B1 |
6579298 | Bruneau | Jun 2003 | B1 |
6626917 | Craig | Sep 2003 | B1 |
6632230 | Barry | Oct 2003 | B2 |
6663639 | Laufer et al. | Dec 2003 | B1 |
6719763 | Chung et al. | Apr 2004 | B2 |
6740030 | Martone et al. | May 2004 | B2 |
6746457 | Dana et al. | Jun 2004 | B2 |
6755843 | Chung et al. | Jun 2004 | B2 |
6773441 | Laufer et al. | Aug 2004 | B1 |
6808491 | Kortenbach et al. | Oct 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6821285 | Laufer et al. | Nov 2004 | B2 |
6835200 | Laufer et al. | Dec 2004 | B2 |
6908427 | Fleener et al. | Jun 2005 | B2 |
6997931 | Sauer et al. | Feb 2006 | B2 |
7056284 | Martone et al. | Jun 2006 | B2 |
7063710 | Takamoto et al. | Jun 2006 | B2 |
7063715 | Onuki et al. | Jun 2006 | B2 |
7094246 | Anderson et al. | Aug 2006 | B2 |
7144401 | Yamamoto et al. | Dec 2006 | B2 |
7147646 | Dana et al. | Dec 2006 | B2 |
7153314 | Laufer et al. | Dec 2006 | B2 |
7220266 | Gambale | May 2007 | B2 |
7232445 | Kortenbach et al. | Jun 2007 | B2 |
7235086 | Sauer et al. | Jun 2007 | B2 |
7285130 | Austin | Oct 2007 | B2 |
7326221 | Sakamoto et al. | Feb 2008 | B2 |
7344545 | Takemoto et al. | Mar 2008 | B2 |
7347863 | Rothe et al. | Mar 2008 | B2 |
7361180 | Saadat et al. | Apr 2008 | B2 |
7530985 | Takemoto et al. | May 2009 | B2 |
7601161 | Nobles et al. | Oct 2009 | B1 |
7618425 | Yamamoto et al. | Nov 2009 | B2 |
7713277 | Laufer et al. | May 2010 | B2 |
7722633 | Laufer et al. | May 2010 | B2 |
7727246 | Sixto, Jr. et al. | Jun 2010 | B2 |
7736373 | Laufer et al. | Jun 2010 | B2 |
7776057 | Laufer et al. | Aug 2010 | B2 |
7776066 | Onuki et al. | Aug 2010 | B2 |
7842051 | Dana et al. | Nov 2010 | B2 |
7846180 | Cerier | Dec 2010 | B2 |
7857823 | Laufer et al. | Dec 2010 | B2 |
7896893 | Laufer et al. | Mar 2011 | B2 |
7918867 | Dana et al. | Apr 2011 | B2 |
7951157 | Gambale | May 2011 | B2 |
7992571 | Gross et al. | Aug 2011 | B2 |
7993368 | Gambale et al. | Aug 2011 | B2 |
8016840 | Takemoto et al. | Sep 2011 | B2 |
8021376 | Takemoto et al. | Sep 2011 | B2 |
8057494 | Laufer et al. | Nov 2011 | B2 |
8062314 | Sixto, Jr. et al. | Nov 2011 | B2 |
8066721 | Kortenbach et al. | Nov 2011 | B2 |
8087856 | Reed | Jan 2012 | B2 |
8105355 | Page et al. | Jan 2012 | B2 |
8211123 | Gross et al. | Jul 2012 | B2 |
8216253 | Saadat et al. | Jul 2012 | B2 |
8226667 | Viola et al. | Jul 2012 | B2 |
8277468 | Laufer et al. | Oct 2012 | B2 |
8287554 | Cerier et al. | Oct 2012 | B2 |
8287556 | Gilkey et al. | Oct 2012 | B2 |
8308765 | Saadat et al. | Nov 2012 | B2 |
8313496 | Sauer et al. | Nov 2012 | B2 |
8361089 | Chu | Jan 2013 | B2 |
8388632 | Gambale | Mar 2013 | B2 |
8425555 | Page et al. | Apr 2013 | B2 |
8454631 | Viola et al. | Jun 2013 | B2 |
8480691 | Dana et al. | Jul 2013 | B2 |
8540735 | Mitelberg et al. | Sep 2013 | B2 |
8551120 | Gambale | Oct 2013 | B2 |
8556914 | Vrba | Oct 2013 | B2 |
8585720 | Gross et al. | Nov 2013 | B2 |
8603123 | Todd | Dec 2013 | B2 |
8632553 | Sakamoto et al. | Jan 2014 | B2 |
8679136 | Mitelberg | Mar 2014 | B2 |
8702735 | Rivers | Apr 2014 | B2 |
8709022 | Stone et al. | Apr 2014 | B2 |
8764771 | Chu | Jul 2014 | B2 |
8882785 | Dicesare et al. | Nov 2014 | B2 |
8926634 | Rothe et al. | Jan 2015 | B2 |
8992570 | Gambale et al. | Mar 2015 | B2 |
9011466 | Overes et al. | Apr 2015 | B2 |
9050126 | Rivers et al. | Jun 2015 | B2 |
9050127 | Bonnette et al. | Jun 2015 | B2 |
9089325 | Mitelberg et al. | Jul 2015 | B2 |
9125646 | Woodard, Jr. et al. | Sep 2015 | B2 |
9198562 | Mitelberg et al. | Dec 2015 | B2 |
9232957 | Adams | Jan 2016 | B2 |
9320515 | Dana et al. | Apr 2016 | B2 |
9474536 | Carrison et al. | Oct 2016 | B2 |
9486126 | West et al. | Nov 2016 | B2 |
9504465 | Chu | Nov 2016 | B2 |
9510817 | Saadat et al. | Dec 2016 | B2 |
9549728 | Chu | Jan 2017 | B2 |
9750494 | Gross et al. | Sep 2017 | B2 |
9788831 | Mitelberg | Oct 2017 | B2 |
9844366 | Woodard, Jr. et al. | Dec 2017 | B2 |
9867610 | Mitelberg et al. | Jan 2018 | B2 |
9931488 | Bunch et al. | Apr 2018 | B2 |
10045871 | Saadat et al. | Aug 2018 | B2 |
10052122 | Higgins et al. | Aug 2018 | B2 |
10130437 | Lee et al. | Nov 2018 | B2 |
10143463 | Dana et al. | Dec 2018 | B2 |
10194902 | Nobles et al. | Feb 2019 | B2 |
10335142 | Raybin et al. | Jul 2019 | B2 |
10736628 | Yates et al. | Aug 2020 | B2 |
11259835 | Smith | Mar 2022 | B2 |
20010004700 | Honeycutt et al. | Jun 2001 | A1 |
20010037121 | McGuckin, Jr. et al. | Nov 2001 | A1 |
20020007190 | Wulfman | Jan 2002 | A1 |
20020058956 | Honeycutt et al. | May 2002 | A1 |
20020107530 | Sauer et al. | Aug 2002 | A1 |
20020151917 | Barry | Oct 2002 | A1 |
20020161384 | Wulfman et al. | Oct 2002 | A1 |
20030093103 | Malackowski et al. | May 2003 | A1 |
20030204205 | Sauer et al. | Oct 2003 | A1 |
20040002699 | Ryan et al. | Jan 2004 | A1 |
20040068270 | Allred, III | Apr 2004 | A1 |
20040138706 | Abrams et al. | Jul 2004 | A1 |
20040186368 | Ramzipoor et al. | Sep 2004 | A1 |
20050004579 | Schneider et al. | Jan 2005 | A1 |
20050015021 | Shiber | Jan 2005 | A1 |
20050033319 | Gambale et al. | Feb 2005 | A1 |
20050240146 | Nash et al. | Oct 2005 | A1 |
20050250985 | Saadat et al. | Nov 2005 | A1 |
20060074405 | Malackowski et al. | Apr 2006 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060142775 | Heneberry et al. | Jun 2006 | A1 |
20070093841 | Hoogland | Apr 2007 | A1 |
20070239140 | Chechelski et al. | Oct 2007 | A1 |
20070270908 | Stokes et al. | Nov 2007 | A1 |
20080039823 | Shimogami et al. | Feb 2008 | A1 |
20080086148 | Baker et al. | Apr 2008 | A1 |
20080097499 | Nash et al. | Apr 2008 | A1 |
20080103516 | Wulfman | May 2008 | A1 |
20080146965 | Privitera et al. | Jun 2008 | A1 |
20090024085 | To et al. | Jan 2009 | A1 |
20090069829 | Shturman | Mar 2009 | A1 |
20090124975 | Oliver et al. | May 2009 | A1 |
20090177031 | Surti et al. | Jul 2009 | A1 |
20090299392 | Rivers | Dec 2009 | A1 |
20100125276 | Palermo | May 2010 | A1 |
20100137681 | Ewers et al. | Jun 2010 | A1 |
20100198006 | Greenburg et al. | Aug 2010 | A1 |
20100292720 | Thatcher | Nov 2010 | A1 |
20100312263 | Moberg et al. | Dec 2010 | A1 |
20110077673 | Grubac et al. | Mar 2011 | A1 |
20110213391 | Rivers et al. | Sep 2011 | A1 |
20110251554 | Romoscanu | Oct 2011 | A1 |
20110306995 | Moberg | Dec 2011 | A1 |
20120046600 | Kohler | Feb 2012 | A1 |
20120053606 | Schmitz et al. | Mar 2012 | A1 |
20120095461 | Herscher et al. | Apr 2012 | A1 |
20120130410 | Tal et al. | May 2012 | A1 |
20120136348 | Condie et al. | May 2012 | A1 |
20120158023 | Mitelberg et al. | Jun 2012 | A1 |
20120172963 | Ryan et al. | Jul 2012 | A1 |
20120179167 | Wenderow et al. | Jul 2012 | A1 |
20120185031 | Ryan et al. | Jul 2012 | A1 |
20120209176 | Anderson | Aug 2012 | A1 |
20120271327 | West et al. | Oct 2012 | A1 |
20130006248 | Ellis | Jan 2013 | A1 |
20130079763 | Heckel et al. | Mar 2013 | A1 |
20130096581 | Gilkey et al. | Apr 2013 | A1 |
20130103062 | To et al. | Apr 2013 | A1 |
20130253552 | Schoenle et al. | Sep 2013 | A1 |
20130274657 | Zirps et al. | Oct 2013 | A1 |
20130304093 | Serina et al. | Nov 2013 | A1 |
20140100574 | Bono et al. | Apr 2014 | A1 |
20140128668 | Cox et al. | May 2014 | A1 |
20140148835 | Schmitz et al. | May 2014 | A1 |
20140212457 | Rifai | Jul 2014 | A1 |
20140222042 | Kessler et al. | Aug 2014 | A1 |
20140249554 | To et al. | Sep 2014 | A1 |
20140261453 | Carlson | Sep 2014 | A1 |
20140277014 | Higgins et al. | Sep 2014 | A1 |
20140316447 | Ellering et al. | Oct 2014 | A1 |
20140316448 | Higgins | Oct 2014 | A1 |
20140316451 | Higgins et al. | Oct 2014 | A1 |
20140324052 | Carrison et al. | Oct 2014 | A1 |
20150011834 | Ayala et al. | Jan 2015 | A1 |
20150073448 | Rydberg | Mar 2015 | A1 |
20150125807 | Shipley | May 2015 | A1 |
20150126983 | Alvarado et al. | May 2015 | A1 |
20150164540 | Higgins et al. | Jun 2015 | A1 |
20150173776 | Burke et al. | Jun 2015 | A1 |
20150173838 | Murphy et al. | Jun 2015 | A1 |
20150201956 | Higgins et al. | Jul 2015 | A1 |
20150216554 | Kessler et al. | Aug 2015 | A1 |
20150327880 | Wasicek et al. | Nov 2015 | A1 |
20150335348 | Cohen et al. | Nov 2015 | A1 |
20160022307 | Wasdyke et al. | Jan 2016 | A1 |
20160045197 | Mitelberg et al. | Feb 2016 | A1 |
20160157886 | WasDyke et al. | Jun 2016 | A1 |
20160235434 | Smith et al. | Aug 2016 | A1 |
20160235441 | Parkin | Aug 2016 | A1 |
20160287284 | Smith | Oct 2016 | A1 |
20160346003 | Grothe et al. | Dec 2016 | A1 |
20160354107 | Nakano et al. | Dec 2016 | A1 |
20170014146 | Guggenheimer | Jan 2017 | A1 |
20170086817 | Mitelberg | Mar 2017 | A1 |
20170086818 | Mitelberg | Mar 2017 | A1 |
20170181760 | Look et al. | Jun 2017 | A1 |
20170189123 | Govari et al. | Jul 2017 | A1 |
20170273698 | McGuckin, Jr. et al. | Sep 2017 | A1 |
20170296200 | Singer et al. | Oct 2017 | A1 |
20180042602 | Mitelberg et al. | Feb 2018 | A1 |
20180042603 | Mitelberg et al. | Feb 2018 | A1 |
20180153381 | Wei et al. | Jun 2018 | A1 |
20180183179 | Byrd et al. | Jun 2018 | A1 |
20180193056 | Colyer | Jul 2018 | A1 |
20180235604 | Comee et al. | Aug 2018 | A1 |
20180242998 | Dhandhusaria et al. | Aug 2018 | A1 |
20190175211 | Carlson et al. | Jun 2019 | A1 |
20190262032 | Carlson et al. | Aug 2019 | A1 |
20190262034 | Spangler et al. | Aug 2019 | A1 |
20200022764 | Flexman et al. | Jan 2020 | A1 |
20200060718 | Patel et al. | Feb 2020 | A1 |
20200069324 | Deepa | Mar 2020 | A1 |
20200229844 | Rawson et al. | Jul 2020 | A1 |
20200315654 | Patel et al. | Oct 2020 | A1 |
20210172499 | Nino | Jun 2021 | A1 |
Number | Date | Country |
---|---|---|
2682488 | Oct 2008 | CA |
202005022017 | May 2012 | DE |
1520509 | Apr 2005 | EP |
2011446 | Jul 2009 | EP |
2108304 | Oct 2009 | EP |
2508141 | Oct 2012 | EP |
3053534 | Aug 2016 | EP |
3132760 | Feb 2017 | EP |
3192461 | Jul 2017 | EP |
3222228 | Sep 2017 | EP |
3226784 | Sep 2020 | EP |
S2009529 | Apr 2012 | IE |
H10174689 | Jun 1998 | JP |
2001509685 | Jul 2001 | JP |
9629014 | Sep 1996 | WO |
9814124 | Apr 1998 | WO |
0051511 | Sep 2000 | WO |
0056230 | Sep 2000 | WO |
2001054595 | Aug 2001 | WO |
0189393 | Nov 2001 | WO |
0249518 | Jun 2002 | WO |
2004080507 | Sep 2004 | WO |
2008016592 | Feb 2008 | WO |
2008045376 | Apr 2008 | WO |
2008098124 | Aug 2008 | WO |
2010036227 | Apr 2010 | WO |
2010056714 | May 2010 | WO |
2010089727 | Aug 2010 | WO |
2011060192 | May 2011 | WO |
2011106053 | Sep 2011 | WO |
2013158849 | Oct 2013 | WO |
2014106847 | Jul 2014 | WO |
2016001932 | Jan 2016 | WO |
2016144834 | Sep 2016 | WO |
2016200811 | Dec 2016 | WO |
2017087856 | May 2017 | WO |
2018156603 | Aug 2018 | WO |
2019118522 | Jun 2019 | WO |
2019168784 | Sep 2019 | WO |
2020055728 | Mar 2020 | WO |
Entry |
---|
International Search Report and Written Opinion dated Feb. 22, 2022 for International Application No. PCT/US2021/057279. |
International Search Report and Written Opinion dated Aug. 20, 2019 for International Application No. PCT/US2019/033748. |
International Search Report and Written Opinion dated Oct. 1, 2019 for International Application No. PCT/US2019/038006. |
Invitation to Pay Additional Fees dated Sep. 26, 2019 for International Application No. PCT/US2019/037995. |
International Search Report and Written Opinion dated Dec. 6, 2019 for International Application No. PCT/US2019/037995. |
Invitation to Pay Additional Fees dated Nov. 18, 2019 for International Application No. PCT/US2019/049774. |
International Search and Written Opinion dated Sep. 20, 2019 for International Application No. PCT/2019/039312. |
International Search Report and Written Opinion dated Jun. 4, 2021 for International Application No. PCT/US2021/017939. |
International Search Report and Written opinion dated Mar. 28, 2018 for International Application No. PCT/US2018/013587. |
International Search Report and Written Opinion dated Apr. 17, 2019 for International Application No. PCT/US2019/018121. |
International Search Report and Written Opinion dated Apr. 26, 2019, for International Application No. PCT/US2019/019404. |
“What is a PID Controller: Working & Its Applications, 2013, EL-PRO-CUS, URL:https://www.elprocus.com/the-working-of-a-pid-controller/” 17 pages, (Year:2013). |
International Search Report and Written Opinion dated Apr. 26, 2019, for International Application No. PCT/US2019/019631. |
International Search Report and Written Opinion dated Mar. 30, 2020 for International Application No. PCT/US2020/014062. |
International Search Report and Written Opinion dated Jun. 25, 2020 for International Application No. PCT/US2020/012767. |
International Search Report and Written Opinion dated Apr. 22, 2020 for International Application No. PCT/US2020/013764. |
International Search Report and Written Opinion dated Jun. 24, 2020 for International Application No. PCT/US2020/027079. |
International Search Report and Written Opinion dated Sep. 4, 2020 for International Application No. PCT/US2020/038132. |
International Search Report and Written Opinion dated Sep. 7, 2020 for International Application No. PCT/US2020/038145. |
International Search Report and Written Opinion dated Dec. 8, 2020 for International Application No. PCT/US2020/049999. |
Invite to Pay Additional Fees dated Feb. 16, 2021 for International Application No. PCT/US2020/061383. |
International Search Report and Written Opinion dated Jan. 26, 2022 for International Application No. PCT/US2021/056616. |
U.S. Appl. No. 17,706,866, filed Mar. 29, 2022. |
Number | Date | Country | |
---|---|---|---|
20220133347 A1 | May 2022 | US |
Number | Date | Country | |
---|---|---|---|
63108045 | Oct 2020 | US |